Addex Therapeutics (ADXN) Accumulated Expenses: 2022-2025
Historic Accumulated Expenses for Addex Therapeutics (ADXN) over the last 2 years, with Jun 2025 value amounting to $507,758.
- Addex Therapeutics' Accumulated Expenses rose 235.45% to $507,758 in Q2 2025 from the same period last year, while for Jun 2025 it was $507,758, marking a year-over-year increase of 235.45%. This contributed to the annual value of $589,775 for FY2024, which is 57.12% down from last year.
- As of Q2 2025, Addex Therapeutics' Accumulated Expenses stood at $507,758, which was down 100.00% from $721.6 billion recorded in Q1 2025.
- Addex Therapeutics' 5-year Accumulated Expenses high stood at $721.6 billion for Q1 2025, and its period low was -$374,864 during Q2 2024.
- Over the past 3 years, Addex Therapeutics' median Accumulated Expenses value was $970,738 (recorded in 2023), while the average stood at $159.4 billion.
- In the last 5 years, Addex Therapeutics' Accumulated Expenses plummeted by 127.78% in 2024 and then skyrocketed by 257,081,744.94% in 2025.
- Over the past 4 years, Addex Therapeutics' Accumulated Expenses (Quarterly) stood at $1.7 million in 2022, then fell by 16.07% to $1.4 million in 2023, then plummeted by 57.47% to $592,276 in 2024, then surged by 235.45% to $507,758 in 2025.
- Its Accumulated Expenses stands at $507,758 for Q2 2025, versus $721.6 billion for Q1 2025 and $592,276 for Q4 2024.